Statement re Scrip Dividend Scheme / PDMR Share...
Regulatory News
Statement re Scrip Dividend Scheme
05 January 2012
Intermediate Capital Group PLC
SCRIP DIVIDEND SCHEME/ PDMR SHAREHOLDING/ TOTAL VOTING RIGHTS
ADDITIONAL LISTING OF SCRIP DIVIDEND SHARES AND SHAREHOLDINGS OF PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMRs") OR THEIR CONNECTED PERSONS
Intermediate Capital Group PLC (the "Company") announces that, pursuant to the
Company's Scrip Dividend Scheme it has received elections from shareholders to
receive a total of 320,690 Ordinary Shares in the Company in lieu of cash in
respect of all or part of their interim dividend for the year ended 31 March
2012, to be paid on 6 January 2012.
Shareholders holding shares representing 3.25% of the issued share capital
elected to take scrip instead of cash.
The above shares rank pari passu in all respects with the existing issued
ordinary shares in the Company. Application has been made to the UK Listing
Authority for the listing of, and to the London Stock Exchange for the admission
of, these shares to the Official List and to trading on the London Stock
Exchange's Main Market for listed securities and it is expected that dealings
will commence on 6 January 2012.
In addition, the Company wishes to notify the market (as per DTR 5.6.1R) that,
as a result of these allotments, the issued share capital of the Company
consists of 399,907,734 ordinary shares. Each ordinary share carries the right
to one vote in relation to all circumstances at general meetings of the Company.
The Company does not hold any ordinary shares in treasury.
The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FSA's
Disclosure and Transparency Rules.
Intermediate Capital Group plc was notified on 4 January 2012 that Justin
Dowley, Company Chairman, has made a valid election to receive his interim
dividend in the form of shares in accordance with the Company's Scrip Dividend
Scheme. As a result, on 6 January 2012 Justin Dowley will acquire 2,881
ordinary shares in the Company at a price of 243.08 pence per share.
After the acquisition of the scrip dividend shares Justin Dowley's total holding
will be 119,639 Ordinary Shares.
In compliance with the Listing Rules, the Company has submitted to the National
Storage Mechanism each of the following documents previously posted to
shareholders:
a.  Shareholder Circular in respect of Scrip Dividend; and
b.  Scrip Dividend Mandate Form.
Copies of the above documents are available for inspection at:
www.hemscott.com/nsm.do
Investor enquiries:
Intermediate Capital Group plc
Jean-Christophe Rey
Investor Relations
Direct Line: +44(0) 203 201 7768
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Intermediate Capital Group PLC via Thomson Reuters ONE
[HUG#1575214]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.